Grace Therapeutics
GRCE
#10456
Rank
A$58.54 M
Marketcap
A$2.78
Share price
2.41%
Change (1 day)
-39.48%
Change (1 year)

Annual Reports (40-F)

Latest form 40-F annual reports for Grace Therapeutics CIK: 0001444192
The 40-F is the annual report that Canadian companies file with the SEC instead of a 10-K. It contains the annual information form, MD&A and financial statements of Grace Therapeutics

Thumbnail Grace Therapeutics 40-F Annual Report 2013

40-F Annual Report 2013

Language: English

View Annual Report (40-F)